Estrogen- and tamoxifen-associated effects on brain structure and function

@article{Eberling2004EstrogenAT,
  title={Estrogen- and tamoxifen-associated effects on brain structure and function},
  author={J. Eberling and Christine C. Wu and Regina Tong-Turnbeaugh and W. Jagust},
  journal={NeuroImage},
  year={2004},
  volume={21},
  pages={364-371}
}
We evaluated the effects of estrogen and tamoxifen, a selective estrogen receptor modulator, on positron emission tomography (PET) measures of brain glucose metabolism and magnetic resonance imaging (MRI) measures of hippocampal atrophy. Three groups of postmenopausal women were studied, women taking estrogen (ERT+), women with breast cancer taking tamoxifen (TAM), and women not taking estrogen or tamoxifen (ERT-). All subjects received a PET scan, an MRI scan, and cognitive testing. The TAM… Expand
Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls
TLDR
The results of this exploratory study suggest that at least in pre-menopausal women, TAM may exert a widespread negative influence on cognitive abilities. Expand
Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD
TLDR
In conclusion, particular areas of relatively preserved metabolism were seen in women with more years of endogenous estrogen exposure, as well as in women taking estradiol-based formulations or estrogen therapies unopposed by progesterone, together suggesting regionally specific neuroprotective estrogenic effects. Expand
Postmenopausal hormone therapy and regional brain volumes
TLDR
Conjugated equine estrogens with or without MPA are associated with greater brain atrophy among women aged 65 years and older; however, the adverse effects are most evident in women experiencing cognitive deficits before initiating hormone therapy. Expand
Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy
TLDR
HRT is associated with the sparing of grey matter in prefrontal, parietal, and temporal brain regions and white matter in medial temporal lobe regions and longer durations of therapy are associated with greater sparing ofgrey matter tissue. Expand
The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen
TLDR
It is demonstrated that the prefrontal cortex and hippocampus may be affected by tamoxifen treatment, supporting an antagonistic role of tamoxIFen in the long-term treatment of breast cancer patients. Expand
Tamoxifen Improves Cholinergically Modulated Cognitive Performance in Postmenopausal Women
TLDR
Evidence is provided that TMX may act as an estrogen-like agonist to enhance cholinergic system activity and hippocampally mediated learning to affect cognitive performance in older women using a model of anticholinergic drug-induced cognitive dysfunction. Expand
Effects of estrogen therapy on age-related differences in gray matter concentration
TLDR
It is suggested that initiation of ET around the time of menopause may modulate age-related differences in regional gray matter concentration and the functional significance of the findings remains unknown. Expand
Ovarian steroids and their influence on hippocampal memory function and morphology
The ovarian steroids estradiol and progesterone play a critical role in the regulation of hippocampal plasticity. Estradiol has been shown to increase the growth of new spines and synapses and toExpand
Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.
TLDR
A differential effect of postmenopausal ET and EPT on cholinergic neuronal integrity was identified in post menopausal women and the findings are consistent with a preservation of cholinesterase neuronal integrity in the EPT group. Expand
Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer
TLDR
This study investigated the effects of endocrine therapy on cognitive functioning by comparing 28 postmenopausal women with breast cancer to 37 healthy age-equivalent controls, indicating that endocrine Therapy can have detrimental effects on speeded higher brain functions but not necessarily on memory. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 86 REFERENCES
The effects of tamoxifen and estrogen on brain metabolism in elderly women.
TLDR
The reduced concentrations of MI in the brains of women treated with tamoxifen and HRT, compared with those of control women, suggest that tamoxIFen has an effect similar to that of estrogen. Expand
Effects of Estrogen Replacement Therapy on PET Cerebral Blood Flow and Neuropsychological Performance
TLDR
Findings confirm the previous observation of the beneficial effects of ERT on figural memory and suggest an area for future research to examine mechanisms through which ERT may influence memory and other cognitive abilities. Expand
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition
TLDR
Group differences in longitudinal change in rCBF patterns may reflect one way through which hormones modulate brain activity and contribute to enhanced memory performance among ERT users. Expand
Preliminary evidence that estrogen protects against age-related hippocampal atrophy
TLDR
Findings suggest a neuroprotective effect of estrogen in postmenopausal women, as women subjects taking ERT had larger right hippocampal volumes than women subjects notTaking ERT and larger anterior hippocampalvolume than men subjects andWomen subjects not taking ERTs. Expand
Estrogen use and brain metabolic change in older adults. A preliminary report
TLDR
It is suggested that estrogen use may protect against regional cerebral metabolic decline in postmenopausal women by influencing brain blood flow and metabolism in older adults. Expand
Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.
  • R. Greene
  • Medicine
  • International journal of fertility and women's medicine
  • 2000
TLDR
CBF is diminished in hypoestrogenic women, with regional patterns resembling those of patients with mild to moderate AD, and ERT reversed these detrimental blood flow changes back to a normal pattern after only 6 weeks of CEE therapy. Expand
High-dose estradiol improves cognition for women with AD
TLDR
Although these findings provide further clinical evidence to support a cognitive benefit of estrogen for women with AD, studies evaluating the effect of estradiol administration, in particular, using larger sample sizes and for longer treatment durations are warranted before the therapeutic potential of estrogen replacement for Women with AD can be firmly established. Expand
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
TLDR
The results suggest that estrogen in a therapeutic dosage alters brain activation patterns in postmenopausal women in specific brain regions during the performance of the sorts of memory function that are called upon frequently during any given day. Expand
Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study
TLDR
5-HT(2A)R BP increased in widespread areas of the cerebral cortex following combined E(2) + P administration, which was evident in all cerebral cortex regions examined. Expand
Estrogen, tamoxifen, and the brain.
TLDR
The authors suggested that patients may have received neuroprotective benefits from tamoxifen and HRT, as evidenced by the lowered MI concentrations in their brains, which are highly speculative to interpret as indicative of neuroprotection. Expand
...
1
2
3
4
5
...